Literature DB >> 11121712

Determination of salicylate hydroxylation products as an in vivo oxidative stress marker.

C Coudray1, A Favier.   

Abstract

The in vivo measurement of highly reactive free radicals, such as the z.rad OH radical, is very difficult. New specific markers, which are based on the ability of z.rad OH to attack the benzene rings of aromatic molecules, are currently under investigation. The produced hydroxylated compounds can be measured directly. In vivo, radical metabolism of salicylic acid produces two main hydroxylated derivatives (2,3- and 2,5-dihydroxybenzoic acids). The latter acid can be also produced by enzymatic pathways through the cytochrome P-450 system, while the former acid is reported to be solely formed by direct hydroxyl radical attack. Therefore, measurement of 2, 3-DHBA, following oral administration of the drug acetyl salicylate, could be proposed for assessment of oxidative stress in vivo. In this paper, a sensitive method for the identification and quantification of hydroxylation products from the reaction of z. rad OH with salicylate in vivo is presented. It employs a high performance liquid chromatography and electrochemical detection system. A detection limit of < 1 pmol for the hydroxylation products has been achieved with linear response over at least five orders of magnitude. Using this technique, we measured plasma levels of 2,3- and 2,5-DHBA dihydroxylated derivatives and salicylic acid and determined the ratios following administration of 1 g acetyl salicylate in 20 healthy subjects.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11121712     DOI: 10.1016/s0891-5849(00)00403-2

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  7 in total

Review 1.  Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?

Authors:  Barry Halliwell; Matthew Whiteman
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

2.  Salicytamide: a New Anti-inflammatory Designed Drug Candidate.

Authors:  Karen Marinho Maciel Guedes; Rosivaldo Santos Borges; Enéas Andrade Fontes-Júnior; Andressa Santa Brigida Silva; Luanna Melo Pereira Fernandes; Sabrina Carvalho Cartágenes; Ana Carla Godinho Pinto; Mallone Lopes Silva; Luana Melo Diogo Queiroz; José Luís Fernandes Vieira; Pergentino José Cunha Sousa; Cristiane Socorro Ferraz Maia
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

3.  Effect of induced mild hypothermia on two pro-inflammatory cytokines and oxidative parameters during experimental acute sepsis.

Authors:  Karelle Léon; Christine Moisan; Aline Amérand; Gwladys Poupon; Erwan L'Her
Journal:  Redox Rep       Date:  2013       Impact factor: 4.412

4.  Acute ecotoxicological effects of salicylic acid on the Polychaeta species Hediste diversicolor: evidences of low to moderate pro-oxidative effects.

Authors:  Bruno Nunes
Journal:  Environ Sci Pollut Res Int       Date:  2019-01-25       Impact factor: 4.223

Review 5.  Modification of fibrin structure as a possible cause of thrombolytic resistance.

Authors:  Boguslaw Lipinski
Journal:  J Thromb Thrombolysis       Date:  2010-04       Impact factor: 2.300

6.  Acetylsalicylic acid and salicylic acid present anticancer properties against melanoma by promoting nitric oxide-dependent endoplasmic reticulum stress and apoptosis.

Authors:  Priscila Ausina; Jessica R Branco; Thainá M Demaria; Amanda M Esteves; João Gabriel B Leandro; Alan C Ochioni; Ana Paula M Mendonça; Fernando L Palhano; Marcus F Oliveira; Wassim Abou-Kheir; Mauro Sola-Penna; Patricia Zancan
Journal:  Sci Rep       Date:  2020-11-12       Impact factor: 4.379

7.  Formation primaquine-5,6-orthoquinone, the putative active and toxic metabolite of primaquine via direct oxidation in human erythrocytes.

Authors:  Pius S Fasinu; N P Dhammika Nanayakkara; Yan-Hong Wang; Narayan D Chaurasiya; H M Bandara Herath; James D McChesney; Bharathi Avula; Ikhlas Khan; Babu L Tekwani; Larry A Walker
Journal:  Malar J       Date:  2019-01-30       Impact factor: 2.979

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.